VDRMViaDerma, Inc.

About ViaDerma, Inc. (VDRM)

ViaDerma, Inc. (VDRM) is a Drug Manufacturers - Specialty & Generic company headquartered in Las Vegas, NV, United States whose shares trade over-the-counter on the Pink tier.

ViaDerma, Inc. is a pharmaceutical company committed to bringing new products to the pharmaceutical industry through innovative research and development. The Company manufactures and sells products in fields of medicine ranging from infectious diseases to stem-cell therapy. The Company's products are normally applied topically using a patent-pending delivery system technology. Presently, the products are used within the OTC drug market, i.e. non-prescription. However, the Company believes the delivery system can be used for the prescription medication market as well not only for topical prescription medications but also to turn certain oral medications into topically based medications. In addition to the primary plan of developing and selling new products to the market, the Company is exploring the possibility of licensing the technology to other pharmaceutical companies. In addition to the primary plan of developing and selling new products to the market, the Company is exploring the possibility of licensing the technology to other pharmaceutical companies.

Products and services

ViaDerma Pharma is the distribution arm of ViaDerma a biotechnology company committed to bringing new products quickly to the pharmaceutical industry through innovative research & development in a wide variety of therapeutic areas. ViaDerma's lead product, Vitastem, uses an innovative transdermal delivery method to qpply almost any active ingredient to a topical drug.

VDRM key facts

Ticker symbol

VDRM

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Las Vegas, NV, United States

Country of incorporation

US

Year of incorporation

2007

Employees

6

Estimated market cap

$18.48M (as of Apr 10, 2025)

Shares outstanding

1,233,713,103

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

12/31

Latest filing

Quarterly Report (Sep 30, 2024)

ViaDerma, Inc. leadership

• Chris A. Otiko — President, Secretary, Treasurer
• Zia Choe — Accountant

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with V